Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 225 tulemused
The syndrome of physical or intrinsic allergy of the head; vasomotor rhinitis and the vasodilating pain syndrome, their relationship to myalgia and endolymphatic hydrops (Ménière's disease) and the reasons for including all four as the syndrome of physical allergy of the head.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
[Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Long-term abuse of decongestive nasal drops causes rhinitis medicamentosa due to cytotoxic and ciliary-toxic effects. Nasal obstruction is caused by rebound swelling when the decongestive effect has disappeared. The patient starts using nasal drops more frequently as a result of
Clinical and nasal biopsy response to treatment of perennial rhinitis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Nasal biopsies of patients with perennial rhinitis were performed at baseline and compared with biopsies performed 4 wk after active flunisolide, 50 micrograms four times per day, or placebo. An effort was made to relate histologic findings to other subjective and objective parameters as an
Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
Prolonged application of nasal vasoconstrictors causes rhinitis medicamentosa (RM). Nasal obstruction is induced by rebound swelling when the decongestive effect has disappeared. The aim of this study was to demonstrate ultrastructural changes in RM.
METHODS
Tissue samples of inferior
Carbon dioxide laser turbinate surgery for chronic obstructive rhinitis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
The argon laser was first used to treat chronic obstructive rhinitis. Several other surgical lasers were later used to perform inferior turbinotomy. What is the ideal laser for turbinate surgery?
METHODS
CO(2) laser with its longer wavelength (10.6 micrometer) scatters less on tissues, is
Rhinitis medicamentosa: a review of causes and treatment.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Rhinitis medicamentosa (RM) is a drug-induced, nonallergic form of rhinitis that is associated with prolonged use of topical vasoconstrictors, i.e. local decongestants. Symptoms are exacerbated by the preservative benzalkonium chloride (BKC) in the nasal preparations. Nasal stuffiness is caused by
Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
We aimed to investigate, histopathologic changes in the nasal mucosa of guinea pig's after prolonged administration of oxymetazoline and the development of rhinitis medicamentosa, and the efficacy of mometasone furoate aqueous nasal spray and saline in reversing the ultrastructural changes
[Intranasal laser coagulation in the therapy of vasomotor rhinitis in elderly patients].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Laser coagulation of concha nasalis inferior is essentially atraumatic, bloodless, sterile and causes no edema. The specific effect of a laser beam on microcirculation suggests that laser surgery can be viewed as a pathogenetic method of therapy of vasomotor rhinitis. Laser coagulation of concha
Chronic rhinitis in HTLV-1 carriers: a histopathologic study.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The nasal histopathology of HTLV-1 carriers with chronic rhinitis is unknown.
OBJECTIVE
To describe the histopathological features of HTLV-1 carriers with chronic rhinitis.
METHODS
Biopsies of nasal mucosa of ten HTLV-1 carriers with chronic rhinitis (eight patients with allergic rhinitis and two
Involvement of T-Helper 9 Activation in a Mouse Model of Allergic Rhinitis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND We aimed to investigate the role of T-Helper (TH) 9 cells in the pathogenesis of allergic rhinitis (AR) in mice. MATERIAL AND METHODS An AR model was produced in BALB/c mice, and the viral encoding interleukin (IL)-9 silencing sequence was used to reduce IL-9 expression. The experiment
Upper airway edema resulting from use of Ecballium elaterium.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To present a rare occurrence in ear, nose and throat practice of upper airway allergic edema from use of juice extracted from the fruit of Ecballium elaterium.
BACKGROUND
Ecballium elaterium is a plant indigenous to the Mediterranean region that bears the common name squirting cucumber.
Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Vascular endothelial growth factor (VEGF), a pleiotropic polypeptide that mediates endothelial cell-specific responses such as induction of angiogenesis and vascular leakage, is hyperproduced in a variety of inflammatory disorders. In asthma, VEGF hyperproduction promotes mucosal edema by
A novel botulinum neurotoxin topical gel: Treatment of allergic rhinitis in rats and comparative safety profile.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Rhinitis affects a significant proportion of adults and children with typically seasonal or chronic symptoms. Botulinum neurotoxin type A (BoNTA) is a well-known cholinergic antagonist widely used in a number of approved neurological and esthetic indications. This study was designed to
[The influence of botulinum toxin type A on vasomotor rhinitis and morphological study].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To investigate the effect and mechanisms of botulinum toxin type A(BTA) on vasomotor rhinitis.
METHODS
A retrospective study of 32 patients with vasomotor rhinitis who received BTA injection at 4 points in bilateral nasal cavities with 2.5 units at each point had been done. The state of
Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Rebound nasal mucosal edema may follow the use of topical nasal vasoconstrictors for even a short time. The physician seeing a patient with nasal stuffiness should always ask about the usage of these substances. Management of patients with rhinitis medicamentosa includes making the diagnosis,
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
